ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.41
Delayed Data
As of May 22
 +0.31 / +9.97%
Today’s Change
1.80
Today|||52-Week Range
7.25
-27.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$548.6M

Company Description

ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.

Contact Information

ZIOPHARM Oncology, Inc.
Navy Yard Plaza
Boston Massachusetts 02129
P:(617) 259-1970
Investor Relations:
(617) 502-1881

Employees

Shareholders

Other institutional30.53%
Mutual fund holders20.40%
Individual stakeholders18.08%

Top Executives

There are no executives to display.